A PYMNTS Company

US: DOJ antitrust unit subpoenas Mylan over pricing

By  |  December 6, 2015

The antitrust division of the U.S. Department of Justice has subpoenaed Mylan N.V. for information relating to the pricing and marketing of its generic doxycycline antibiotic products, the drugmaker said on Friday.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The Department of Justice has also sought information on any communication with competitors about the anti-bacterial products, the company said in a regulatory filing, adding it would cooperate with the federal agency.

    The nearly 40-year-old antibiotic is used to treat bacterial infections such as acne, pneumonia, Lyme disease, chlamydia and syphilis.

    Competitors Endo International and Allergan Inc have also received similar subpoenas, according to regulatory filings made by them in November and August.

    U.S. drugmakers have been under increased pressure from the government, insurers and corporations over steep increases in the prices of generic drugs.

    Full content: Reuters

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.